AVDL News and Press, Avadel Pharmaceuticals plc From 11/14/23

2023-11-14 16:00:00 ET Summary Avadel Pharmaceuticals reported strong Q3 earnings for Lumryz, exceeding consensus estimates and demonstrating successful market launch. Avadel's strategic market positioning and focus on high-volume prescribers contribute to its strong market positi...

2023-11-12 03:02:52 ET Summary Lumryz's once-at-bedtime dosing shows clinical and market promise, with early revenue and patient adoption. Avadel faces high operating expenses and cash burn, raising concerns despite a solid liquidity position. Generic competition and supply ch...

2023-11-08 13:48:10 ET Avadel Pharmaceuticals PLC (AVDL) Q3 2023 Earnings Conference Call November 08, 2023, 08:30 ET Company Participants Austin Murtagh - Stern Investor Relations Gregory Divis - CEO & Director Richard Kim - Chief Commercial Officer Jenn...

2023-11-08 07:15:10 ET More on Avadel Pharmaceuticals Avadel Pharmaceuticals: A Resilient Buy; A Comprehensive Assessment Of Potential Prospects Seeking Alpha’s Quant Rating on Avadel Pharmaceuticals Historical earnings data for Avadel Pharmaceuticals ...

-- $7.0 million in third quarter LUMRYZ™ net revenue from U.S. commercial launch -- -- Generated robust demand for LUMRYZ with greater than 1,000 patients enrolled in RYZUP TM and more than 400 patients initiating therapy as of September 30 -- -- LUMRYZ to be ...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

Avadel Pharmaceuticals plc (AVDL) is expected to report $-0.35 for Q3 2023

2023-11-07 12:30:52 ET More on Avadel Pharmaceuticals Avadel Pharmaceuticals: A Resilient Buy; A Comprehensive Assessment Of Potential Prospects Avadel Pharmaceuticals plc (AVDL) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Avadel Pharmaceu...

2023-10-31 17:24:37 ET Gainers: Freshworks (FRSH) +5% . Verve Therapeutics ( VERV ) +3% . Expensify ( EXFY ) +3% . REGENXBIO ( RGNX ) +3% . ACI Worldwide ( ACIW ) +3% . Losers: Big 5 Sporting Goods ( BGFV ) -11% . ...

DUBLIN, Ireland, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, November 8, 2023, to p...